Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B De Strooper

Showing results (1-10 of 66) with videos related to

Pageof 7
Sort By:
Trends in Neurosciences|September 11, 1999
Presenilins: molecular switches between proteolysis and signal transductionW Annaert, B De Strooper
Verhandelingen - Koninklijke Academie Voor Geneeskunde Van Belgie|April 13, 2004
[Secretases as therapeutic targets for the treatment of Alzheimer's disease]T Dejaegere, B de Strooper
Journal of Cell Science|May 12, 2000
Proteolytic processing and cell biological functions of the amyloid precursor proteinB De Strooper, W Annaert
Science (New York, N.Y.)|November 5, 1999
The presenilins in Alzheimer's disease--proteolysis holds the keyC Haass, B De Strooper
European Archives of Psychiatry and Clinical Neuroscience|February 1, 2000
The function of presenilin-1 in amyloid beta-peptide generation and brain developmentP Saftig, D Hartmann, B De Strooper
Current Biology : CB|July 27, 1999
Presenilin-1 deficiency leads to loss of Cajal-Retzius neurons and cortical dysplasia similar to human type 2 lissencephalyD Hartmann, B De Strooper, P Saftig
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|June 21, 2001
Secretases as therapeutic targets for the treatment of Alzheimer's diseaseD I Dominguez, B De Strooper, W Annaert
Annals of the New York Academy of Sciences|February 24, 2001
Presenilin function in APP processingW Annaert, P Cupers, P Saftig, et al.
Fluids and Barriers of the CNS|October 15, 2020
Identification and in vivo characterization of a brain-penetrating nanobodyY Wouters, T Jaspers, B De Strooper, et al.
Current Opinion in Molecular Therapeutics|March 16, 2001
Gene therapeutic strategies for neurodegenerative diseasesV Baekelandt, B De Strooper, B Nuttin, et al.
Pageof 7

Showing results (1-10 of 66) with videos related to

Sort By:
Pageof 7
Trends in Neurosciences|September 11, 1999
Presenilins: molecular switches between proteolysis and signal transductionW Annaert, B De Strooper
Verhandelingen - Koninklijke Academie Voor Geneeskunde Van Belgie|April 13, 2004
[Secretases as therapeutic targets for the treatment of Alzheimer's disease]T Dejaegere, B de Strooper
Journal of Cell Science|May 12, 2000
Proteolytic processing and cell biological functions of the amyloid precursor proteinB De Strooper, W Annaert
Science (New York, N.Y.)|November 5, 1999
The presenilins in Alzheimer's disease--proteolysis holds the keyC Haass, B De Strooper
European Archives of Psychiatry and Clinical Neuroscience|February 1, 2000
The function of presenilin-1 in amyloid beta-peptide generation and brain developmentP Saftig, D Hartmann, B De Strooper
Current Biology : CB|July 27, 1999
Presenilin-1 deficiency leads to loss of Cajal-Retzius neurons and cortical dysplasia similar to human type 2 lissencephalyD Hartmann, B De Strooper, P Saftig
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|June 21, 2001
Secretases as therapeutic targets for the treatment of Alzheimer's diseaseD I Dominguez, B De Strooper, W Annaert
Annals of the New York Academy of Sciences|February 24, 2001
Presenilin function in APP processingW Annaert, P Cupers, P Saftig, et al.
Fluids and Barriers of the CNS|October 15, 2020
Identification and in vivo characterization of a brain-penetrating nanobodyY Wouters, T Jaspers, B De Strooper, et al.
Current Opinion in Molecular Therapeutics|March 16, 2001
Gene therapeutic strategies for neurodegenerative diseasesV Baekelandt, B De Strooper, B Nuttin, et al.
Pageof 7